STEPHANIE RIOLO: Open Payments
NPI 1942237425 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 22 payments from 10 companies in 2025. Trend: 2023 $6,648 · 2024 $87 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $191 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Neurocrine BioSciences, Inc. | 3 | $49 |
| Noven Therapeutics, LLC | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Orexo US, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: COBENFY, REXULTI, INVEGA SUSTENNA, INGREZZA, Xelstrym, UZEDY, ABILIFY MAINTENA, CAPLYTA.
Industry payments across OH — which companies pay providers there.
